Cat. #162359
UNG2-KO HAP1 cell line
Cat. #: 162359
Sub-type: Continuous
Unit size: 1x10^6 cells / vial
Organism: Human
Tissue: Blood
Disease: Chronic myeloid leukaemia
Model: Knock-Out
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Bodil Merete Kavli
Institute: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: UNG2-KO HAP1 cell line
- Cancer: Blood cancer
- Tool sub type: Continuous
- Parental cell: HAP1
- Organism: Human
- Gender: Male
- Tissue: Blood
- Donor: 39 years old
- Disease: Chronic myeloid leukaemia
- Model: Knock-Out
- Model description: UNG2 knock out using CRISPR-Cas9
- Crispr: Yes
- Description: Human chronic myeloid leukaemia HAP1 cell line with abolished expression of UNG2
- Biosafety level: 2
Target Details
- Target: UNG2
Handling
- Format: Frozen
- Passage number: Human chronic myeloid leukaemia HAP1 cell line UNG2 knock out using CRISPR-Cas9
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Cultured in antibiotics: Yes, penicillin/streptomycin
References
- Sarno et al., 2019. Nucleic Acids Res. 47(9):4569-4585, PMID: 30838409
